Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Repligen's Business Segments
Repligen's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 204
Regions Reported
-
Revenue by Product & Service Category -
- Product100%
- Royalty0%
Revenue by Product & Service Category -
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 204 | 100% |
| Royalty | $ 0 | 0% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Repligen
Repligen Corp is a biotechnology company that specializes in the manufacture and supply of bioprocessing products and technologies.
The company's product portfolio includes Protein A and G ligands, affinity chromatography resins, growth factor supplements for cell culture, and filtration products for virus and gene therapy production.
Repligen Corp was founded in 1981 and is headquartered in Waltham, Massachusetts.
The company's manufacturing facilities are located in Waltham, Massachusetts and Lund, Sweden.
Repligen Corp serves customers in the biopharmaceutical and biotechnology industries worldwide.
The company has a strong focus on the development of novel and innovative technologies that enhance productivity and efficiency in bioprocessing.
This has led to the creation of several proprietary technologies such as the OPUS pre-packed chromatography columns and the ATF (Alternating Tangential Flow) system for high-density cell culture perfusion.
One of Repligen Corp's key strengths is its ability to meet the stringent quality standards of the bioprocessing industry.
The company is ISO 9001:2015 certified and adheres to Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) guidelines.
Overall, Repligen Corp is an established player in the bioprocessing industry with a strong track record of innovation and quality.
The company's focus on the development of new products and technologies that increase the efficiency and productivity of bioprocessing is expected to position it for continued growth and success in the future.
The company's product portfolio includes Protein A and G ligands, affinity chromatography resins, growth factor supplements for cell culture, and filtration products for virus and gene therapy production.
Repligen Corp was founded in 1981 and is headquartered in Waltham, Massachusetts.
The company's manufacturing facilities are located in Waltham, Massachusetts and Lund, Sweden.
Repligen Corp serves customers in the biopharmaceutical and biotechnology industries worldwide.
The company has a strong focus on the development of novel and innovative technologies that enhance productivity and efficiency in bioprocessing.
This has led to the creation of several proprietary technologies such as the OPUS pre-packed chromatography columns and the ATF (Alternating Tangential Flow) system for high-density cell culture perfusion.
One of Repligen Corp's key strengths is its ability to meet the stringent quality standards of the bioprocessing industry.
The company is ISO 9001:2015 certified and adheres to Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) guidelines.
Overall, Repligen Corp is an established player in the bioprocessing industry with a strong track record of innovation and quality.
The company's focus on the development of new products and technologies that increase the efficiency and productivity of bioprocessing is expected to position it for continued growth and success in the future.
Repligen Corp is a prominent life sciences company recognized for its innovative contributions to bioprocessing technologies and advanced biomedical materials that facilitate the development and manufacturing of biopharmaceutical drugs. The company comprises several key segments, alongside a wide array of products and services, reflecting its commitment to advancing the life sciences field.
Segments
1. Bioprocessing
The Bioprocessing segment is fundamental to Repligens operations, focusing on the essential processes involved in the cultivation, maintenance, and purification of cells and biological products. This segment caters to various stakeholders in the biopharmaceutical industry, offering a selection of cutting-edge technologies designed to enhance productivity and efficiency in biomanufacturing.
Diagnostic
This segment addresses the growing need for advanced diagnostic solutions, particularly in the neurological field. Repligens diagnostic offerings are rooted in high-quality, non-invasive technologies that enable effective detection and management of peripheral nerve function, contributing to improved patient outcomes in medical procedures.
Products and Services
1. Bioreactors
Repligen provides a comprehensive suite of bioreactors tailored for optimal cell growth and maintenance within carefully controlled environments. Key offerings include:
- XCelle ATF Systems: These single-use bioreactors enhance cell culture performance through improved oxygenation and nutrient delivery, resulting in higher product yield and quality.
Chromatography Resins
The company’s chromatography resins are pivotal in the separation and purification of proteins, a crucial step in biopharmaceutical production. Notable products include:
- Protein A and Protein G Resins: These affinity chromatography resins are critical for the purification of monoclonal antibodies.
- Ion Exchange Resins: Used for protein purification based on charge differences, optimizing yields and purity.
Filtration
Repligen offers a variety of advanced filtration technologies that support the overall bioprocess. Key products include:
- Tangential Flow Filtration (TFF) Systems: These systems are designed to improve the efficiency and performance of downstream processing while ensuring high product recovery rates and reducing processing time.
Pre-packed Columns
The company features a diverse selection of pre-packed chromatography columns, which are available in various formats and sizes suitable for multiple scales of research and manufacturing processes. They provide convenience and consistency in bioprocesses, allowing for seamless transitions from development to commercial production.
Proteins & Other Biologics
Repligen’s expertise extends to the purification of proteins and biologics through an array of products such as:
- Recombinant Proteins: These are essential for various research applications and therapeutic developments.
- Immunoaffinity Purification Solutions: Including Protein A resins that facilitate downstream purification processes.
Diagnostic Solutions
The diagnostic offerings from Repligen emphasize non-invasive technologies that are instrumental in monitoring nerve and muscle function. The flagship product:
- Prontoe-Plus: This device is designed for the detection of peripheral nerve function, enhancing clinical assessments during medical evaluations.
Biomedical Materials
In the realm of biomedical materials, Repligen provides essential products that encompass:
- Cell Culture Products: Covering a range of recombinant proteins, cytokines, and extracellular matrix (ECM) proteins crucial for supporting cell growth and functionality in research and therapeutic applications.
- Materials for Medical Device Development: Supporting advancements in biomaterial design and manufacturing processes.
Conclusion
Repligen Corps extensive range of products and services across its bioprocessing, diagnostic, and biomedical materials segments signifies its leadership in the life sciences industry. The innovative solutions provided by the company not only streamline the biopharmaceutical manufacturing process but also enhance the quality and efficiency of drug development, underscoring Repligens commitment to advancing healthcare and bioprocessing technologies. Through its diverse portfolio, Repligen aims to address complex challenges in biomanufacturing and diagnostics, ensuring high-quality and effective outcomes for bioprocessing and therapeutic needs.
Segments
1. Bioprocessing
The Bioprocessing segment is fundamental to Repligens operations, focusing on the essential processes involved in the cultivation, maintenance, and purification of cells and biological products. This segment caters to various stakeholders in the biopharmaceutical industry, offering a selection of cutting-edge technologies designed to enhance productivity and efficiency in biomanufacturing.
Diagnostic
This segment addresses the growing need for advanced diagnostic solutions, particularly in the neurological field. Repligens diagnostic offerings are rooted in high-quality, non-invasive technologies that enable effective detection and management of peripheral nerve function, contributing to improved patient outcomes in medical procedures.
Products and Services
1. Bioreactors
Repligen provides a comprehensive suite of bioreactors tailored for optimal cell growth and maintenance within carefully controlled environments. Key offerings include:
- XCelle ATF Systems: These single-use bioreactors enhance cell culture performance through improved oxygenation and nutrient delivery, resulting in higher product yield and quality.
Chromatography Resins
The company’s chromatography resins are pivotal in the separation and purification of proteins, a crucial step in biopharmaceutical production. Notable products include:
- Protein A and Protein G Resins: These affinity chromatography resins are critical for the purification of monoclonal antibodies.
- Ion Exchange Resins: Used for protein purification based on charge differences, optimizing yields and purity.
Filtration
Repligen offers a variety of advanced filtration technologies that support the overall bioprocess. Key products include:
- Tangential Flow Filtration (TFF) Systems: These systems are designed to improve the efficiency and performance of downstream processing while ensuring high product recovery rates and reducing processing time.
Pre-packed Columns
The company features a diverse selection of pre-packed chromatography columns, which are available in various formats and sizes suitable for multiple scales of research and manufacturing processes. They provide convenience and consistency in bioprocesses, allowing for seamless transitions from development to commercial production.
Proteins & Other Biologics
Repligen’s expertise extends to the purification of proteins and biologics through an array of products such as:
- Recombinant Proteins: These are essential for various research applications and therapeutic developments.
- Immunoaffinity Purification Solutions: Including Protein A resins that facilitate downstream purification processes.
Diagnostic Solutions
The diagnostic offerings from Repligen emphasize non-invasive technologies that are instrumental in monitoring nerve and muscle function. The flagship product:
- Prontoe-Plus: This device is designed for the detection of peripheral nerve function, enhancing clinical assessments during medical evaluations.
Biomedical Materials
In the realm of biomedical materials, Repligen provides essential products that encompass:
- Cell Culture Products: Covering a range of recombinant proteins, cytokines, and extracellular matrix (ECM) proteins crucial for supporting cell growth and functionality in research and therapeutic applications.
- Materials for Medical Device Development: Supporting advancements in biomaterial design and manufacturing processes.
Conclusion
Repligen Corps extensive range of products and services across its bioprocessing, diagnostic, and biomedical materials segments signifies its leadership in the life sciences industry. The innovative solutions provided by the company not only streamline the biopharmaceutical manufacturing process but also enhance the quality and efficiency of drug development, underscoring Repligens commitment to advancing healthcare and bioprocessing technologies. Through its diverse portfolio, Repligen aims to address complex challenges in biomanufacturing and diagnostics, ensuring high-quality and effective outcomes for bioprocessing and therapeutic needs.